Publisher： Bentham Science Publishers
E-ISSN： 1873-5592|12|6|909-921
ISSN： 1389-4501
Source： Current Drug Targets, Vol.12, Iss.6, 2011-06, pp. : 909-921
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
The mu opioid receptor: A new target for cancer therapy?
Cancer, Vol. 121, Iss. 16, 2015-08 ,pp. :
Access to resources
Recommend
NK-1 Receptor Antagonists: A New Paradigm in Pharmacological Therapy
Current Medicinal Chemistry, Vol. 18, Iss. 12, 2011-04 ,pp. :
A New Frontier in the Treatment of Cancer: NK-1 Receptor Antagonists
Current Medicinal Chemistry, Vol. 17, Iss. 6, 2010-02 ,pp. :
By Muññoz Miguel Bernabeu-Wittel Joséé Coveññas Rafael
Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 7, 2011-07 ,pp. :
Receptor Tyrosine Kinases as Target for Anti-Cancer Therapy
Current Pharmaceutical Design, Vol. 8, Iss. 22, 2002-10 ,pp. :